BC Week In Review | Dec 10, 2007
Company News

Advanced Viral management update

Advanced Viral Research Corp. (ADVR), Yonkers, N.Y.   Business: Cancer, Infectious   Hired: Vincent Gullo as CSO, formerly VP of drug discovery at Cetek Corp. ; and Dallas Hughes as VP of research, formerly SVP...
BC Week In Review | Dec 10, 2007
Company News

Advanced Viral deal

ADVR acquired two cancer compounds and affinity based purification ( AFP ) high throughput drug screening technology from Vincent Gullo and Dallas Hughes, the founding scientists of Cetek Corp. (Marlborough, Mass.). ADVR also will receive rights to...
BC Week In Review | Jan 9, 2006
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass.   Business: High throughput screening   Hired: Barry Berkowitz as president and CEO, formerly president and CEO at Scion Pharmaceuticals Inc.; he replaces James Little, who becomes SVP of business development...
BC Extra | Jan 4, 2006
Financial News

Cetek raises $10 million

Cetek (Marlborough, Mass.) raised $10 million in a series E round. Investors included Argonaut ; Ventry Industries; Gainesborough Investments; Cetek Chairman James Waters; and Stata Ventures. Cetek has two preclinical programs in cancer and two...
BC Extra | Apr 12, 2004
Financial News

Cetek raises $16 million

High throughput screening company Cetek (Marlborough, Mass.) raised $16 million in a series D round. Investors included John and Stephen Davis; Gainsborough Investments; Argonaut Private Equity; and James Waters. Cetek uses its Natural Product Factory...
BC Week In Review | Feb 9, 2004
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass.   Business: High throughput screening   Hired: Vincent Gullo as VP of drug discovery, formerly a senior director at Schering-Plough Research Institute  ...
BC Week In Review | Jan 19, 2004
Company News

Scynexis management update

Scynexis Inc. , Research Triangle Park, N.C.   Business: Chemistry   Hired: Charles Osborne as CFO, formerly CFO of Nobex Corp. ; Brian Schwab as chief licensing officer and general counsel, formerly deputy general counsel for...
BC Week In Review | Jan 12, 2004
Company News

Cetek, University of Texas M.D. Anderson Cancer Center deal

Using Cetek's capillary electrophoresis (CE) assay, the partners will discover and develop small molecule therapeutics isolated from natural extracts to treat cancer and inflammatory diseases. Cetek Corp. , Marlborough, Mass.   University of Texas M.D. Anderson...
BC Week In Review | Jan 20, 2003
Company News

Cetek, J&J deal

The companies renewed a 2001 deal under which Cetek is developing capillary electrophoresis-based screening assays for targets provided by the R.W. Johnson Pharmaceutical Research Institute, a JNJ company. Cetek will use the assays to screen...
BC Week In Review | Aug 26, 2002
Company News

Cetek, Essential deal

Cetek will provide high throughput screening services for ETRX and its partner Fujisawa Pharmaceutical Co. Ltd. (Osaka, Japan) for use in researching antibiotics. Under a separate 2001 deal, ETRX and Cetek are using ETRX’s Validated...
Items per page:
1 - 10 of 42
BC Week In Review | Dec 10, 2007
Company News

Advanced Viral management update

Advanced Viral Research Corp. (ADVR), Yonkers, N.Y.   Business: Cancer, Infectious   Hired: Vincent Gullo as CSO, formerly VP of drug discovery at Cetek Corp. ; and Dallas Hughes as VP of research, formerly SVP...
BC Week In Review | Dec 10, 2007
Company News

Advanced Viral deal

ADVR acquired two cancer compounds and affinity based purification ( AFP ) high throughput drug screening technology from Vincent Gullo and Dallas Hughes, the founding scientists of Cetek Corp. (Marlborough, Mass.). ADVR also will receive rights to...
BC Week In Review | Jan 9, 2006
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass.   Business: High throughput screening   Hired: Barry Berkowitz as president and CEO, formerly president and CEO at Scion Pharmaceuticals Inc.; he replaces James Little, who becomes SVP of business development...
BC Extra | Jan 4, 2006
Financial News

Cetek raises $10 million

Cetek (Marlborough, Mass.) raised $10 million in a series E round. Investors included Argonaut ; Ventry Industries; Gainesborough Investments; Cetek Chairman James Waters; and Stata Ventures. Cetek has two preclinical programs in cancer and two...
BC Extra | Apr 12, 2004
Financial News

Cetek raises $16 million

High throughput screening company Cetek (Marlborough, Mass.) raised $16 million in a series D round. Investors included John and Stephen Davis; Gainsborough Investments; Argonaut Private Equity; and James Waters. Cetek uses its Natural Product Factory...
BC Week In Review | Feb 9, 2004
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass.   Business: High throughput screening   Hired: Vincent Gullo as VP of drug discovery, formerly a senior director at Schering-Plough Research Institute  ...
BC Week In Review | Jan 19, 2004
Company News

Scynexis management update

Scynexis Inc. , Research Triangle Park, N.C.   Business: Chemistry   Hired: Charles Osborne as CFO, formerly CFO of Nobex Corp. ; Brian Schwab as chief licensing officer and general counsel, formerly deputy general counsel for...
BC Week In Review | Jan 12, 2004
Company News

Cetek, University of Texas M.D. Anderson Cancer Center deal

Using Cetek's capillary electrophoresis (CE) assay, the partners will discover and develop small molecule therapeutics isolated from natural extracts to treat cancer and inflammatory diseases. Cetek Corp. , Marlborough, Mass.   University of Texas M.D. Anderson...
BC Week In Review | Jan 20, 2003
Company News

Cetek, J&J deal

The companies renewed a 2001 deal under which Cetek is developing capillary electrophoresis-based screening assays for targets provided by the R.W. Johnson Pharmaceutical Research Institute, a JNJ company. Cetek will use the assays to screen...
BC Week In Review | Aug 26, 2002
Company News

Cetek, Essential deal

Cetek will provide high throughput screening services for ETRX and its partner Fujisawa Pharmaceutical Co. Ltd. (Osaka, Japan) for use in researching antibiotics. Under a separate 2001 deal, ETRX and Cetek are using ETRX’s Validated...
Items per page:
1 - 10 of 42